{"id":1068001,"date":"2020-11-05T09:55:58","date_gmt":"2020-11-05T14:55:58","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/arch-biopartners-announces-dosing-of-first-patient-in-turkey-in-phase-ii-trial-of-lsalt-peptide-to-treat-complications-from-covid-19\/"},"modified":"2024-08-18T11:41:48","modified_gmt":"2024-08-18T15:41:48","slug":"arch-biopartners-announces-dosing-of-first-patient-in-turkey-in-phase-ii-trial-of-lsalt-peptide-to-treat-complications-from-covid-19","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/arch-biopartners-announces-dosing-of-first-patient-in-turkey-in-phase-ii-trial-of-lsalt-peptide-to-treat-complications-from-covid-19.php","title":{"rendered":"Arch Biopartners Announces Dosing of First Patient in Turkey in Phase II Trial of LSALT peptide to Treat Complications from Covid-19"},"content":{"rendered":"<p><![CDATA[TORONTO, Nov.  05, 2020  (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (\u201cArch\u201d or the \u201cCompany\u201d) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that patient dosing in Turkey has begun in the Phase II trial of its lead drug LSALT peptide, targeting prevention of acute lung injury, acute kidney injury and other complications caused by inflammation in hospitalized patients with moderate to severe cases of COVID-19.]]><\/p>\n<p>Follow this link:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2020\/11\/05\/2121049\/0\/en\/Arch-Biopartners-Announces-Dosing-of-First-Patient-in-Turkey-in-Phase-II-Trial-of-LSALT-peptide-to-Treat-Complications-from-Covid-19.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Arch Biopartners Announces Dosing of First Patient in Turkey in Phase II Trial of LSALT peptide to Treat Complications from Covid-19\">Arch Biopartners Announces Dosing of First Patient in Turkey in Phase II Trial of LSALT peptide to Treat Complications from Covid-19<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Follow this link: Arch Biopartners Announces Dosing of First Patient in Turkey in Phase II Trial of LSALT peptide to Treat Complications from Covid-19 <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/arch-biopartners-announces-dosing-of-first-patient-in-turkey-in-phase-ii-trial-of-lsalt-peptide-to-treat-complications-from-covid-19.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068001","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068001"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068001"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068001\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068001"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068001"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068001"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}